MREM Press Releases
- March 10, 2020
AmBank Reports One Non-Executive Director at Subsidiary Diagnosed With COVID-19
KUALA LUMPUR, March 10 (Bernama) — AMMB Holdings Berhad (AMMB) reported that a Non-Executive Director at one of its subsidiaries tested positive for COVID-19. According to preliminary checks, it has been determined that for the past 10 days, the Director was not in contact with any staff and had not visited
- March 10, 2020
CIMB Group CEO Relinquishes Post
KUALA LUMPUR, March 10 (Bernama) — CIMB Group Holdings Berhad (“CIMB” or “the Group”), on 9 March 2020 announced that Tengku Dato’ Sri Zafrul has resigned as its Group CEO and CEO of CIMB Bank Berhad with immediate effect. Tengku Dato’ Sri Zafrul has also resigned from all other board
- March 9, 2020
GOE: Legendary Maverick Hunter Zero Added in New TEPPEN Expansion ‘Haunted By Memories’
TOKYO, March 9 (Bernama-BUSINESS WIRE) — Get ready to go from Zero to Hero! GungHo Online Entertainment (GOE) (TOKYO:3765) announced that the Maverick Hunter, Zero from the Mega Man X series will join TEPPEN as one of the game’s playable Heroes. To view the trailer, click here. The Maverick Hunter, Zero is now available as a playable Hero
- March 9, 2020
Agrobank Announces 25bps Rate Adjustment After OPR Cut
KUALA LUMPUR, March 9 (Bernama) — Agrobank today announced its latest financing rate by reducing the Base Rate (BR) to 3.10% and Base Financing Rate (BFR) to 6.25%. In line with the revision, Agrobank will also adjust downwards its Fixed Return Islamic Accounts (FRIA-i) across all tenures. This is in response to
- March 9, 2020
Shane Gong Joins Evercore as Managing Director in the Firm’s Private Capital Advisory Group
SINGAPORE, March 9 (Bernama-BUSINESS WIRE) — Evercore (NYSE: EVR) announced today that Shane Gong has joined the Firm’s Private Capital Advisory group (“PCA”) as a Managing Director. Mr. Gong will be based in Singapore and lead the Firm’s PCA business across the Asia Pacific region, focusing on institutional investors and
- March 9, 2020
VISTA Eye Specialist To Safeguard The Clinic Environment With Air & Surface Sterilization Technology
Medklinn Sterilizers to be installed at all 11 centers nationwide. KUALA LUMPUR, Malaysia, March 9 (Bernama-PRNewswire) — VISTA Eye Specialist has announced today that it has signed an agreement with Medklinn International Sdn Bhd, a world-renowned company focused on improving air quality and surface sterilization, to install Medklinn Air & Surface Sterilizers in all
- March 9, 2020
First Patient Dosed In Phase I Clinical Trial Using RoosterBio’s Cellular Starting Materials
FREDERICK, Md., March 9 (Bernama-GLOBE NEWSWIRE) — RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, announces today a significant milestone in the regenerative medicine field with the dosing of the first patient using its innovative cellular starting materials. The patient has
- March 6, 2020
Cradle Unveils The Coach And Grow Programme 2020 For Malaysian Start-ups
KUALA LUMPUR, March 6 (Bernama) — Malaysia’s early stage start-up influencer, Cradle Fund Sdn Bhd (Cradle) together with Proficeo Consultants Sdn Bhd (Proficeo), today launched the Coach and Grow Programme (CGP) 2020 to support the fast growing innovation ecosystem in the country. The CGP is a specialised coaching programme focused on nurturing start-ups
- March 6, 2020
Al-Salām Seeks To Raise C.RM93.0 M Via Private Placement
KUALA LUMPUR, March 6 (Bernama) — Since its listing in September 2015, Al-Salām Real Estate Investment Trust (“Al-Salām”) has grown the size of its portfolio from RM903 million to around RM1.2 billion via the acquisition of Mydin Hypermarket Gong Badak and an additional 17 QSR properties, based on triple net lease arrangement, in
- March 6, 2020
Sabin Vaccine Institute Strengthens Ebola Sudan and Marburg Vaccines Program With Additional NIAID Partnership
Washington, DC, March 6 (Bernama-GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) today announced that it has partnered with the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), to manufacture prototype ChAd3 vectored Ebola Sudan and Marburg vaccines to be used for further clinical evaluation and outbreak
